Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 25, 2023, titled "Sun Pharma Launches SEZABY (phenobarbital sodium) in the U.S. for Treatment of Neonatal Seizures".
Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated January 25, 2023, titled "Sun Pharma Launches SEZABY (phenobarbital sodium) in the U.S. for Treatment of Neonatal Seizures".